These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29655587)

  • 1. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.
    Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.
    Dafsari HS; Petry-Schmelzer JN; Ray-Chaudhuri K; Ashkan K; Weis L; Dembek TA; Samuel M; Rizos A; Silverdale M; Barbe MT; Fink GR; Evans J; Martinez-Martin P; Antonini A; Visser-Vandewalle V; Timmermann L; ;
    Brain Stimul; 2018; 11(4):904-912. PubMed ID: 29655586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.
    Jost ST; Visser-Vandewalle V; Rizos A; Loehrer PA; Silverdale M; Evans J; Samuel M; Petry-Schmelzer JN; Sauerbier A; Gronostay A; Barbe MT; Fink GR; Ashkan K; Antonini A; Martinez-Martin P; Chaudhuri KR; Timmermann L; Dafsari HS;
    NPJ Parkinsons Dis; 2021 Jun; 7(1):48. PubMed ID: 34103534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
    Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS;
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.
    Dafsari HS; Reker P; Stalinski L; Silverdale M; Rizos A; Ashkan K; Barbe MT; Fink GR; Evans J; Steffen J; Samuel M; Dembek TA; Visser-Vandewalle V; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Timmermann L;
    Mov Disord; 2018 Jan; 33(1):99-107. PubMed ID: 29150860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
    Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.
    Petry-Schmelzer JN; Krause M; Dembek TA; Horn A; Evans J; Ashkan K; Rizos A; Silverdale M; Schumacher W; Sack C; Loehrer PA; Fink GR; Fonoff ET; Martinez-Martin P; Antonini A; Barbe MT; Visser-Vandewalle V; Ray-Chaudhuri K; Timmermann L; Dafsari HS;
    Brain; 2019 Nov; 142(11):3592-3604. PubMed ID: 31553039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Ashkan K; Sachse L; Mahlstedt P; Silverdale M; Rizos A; Strack M; Jost ST; Reker P; Samuel M; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Timmermann L;
    J Neurol; 2020 Jun; 267(6):1830-1841. PubMed ID: 32152689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratifying quality of life outcome in subthalamic stimulation for Parkinson's disease.
    Gronostay A; Jost ST; Silverdale M; Rizos A; Loehrer PA; Evans J; Sauerbier A; Indi D; Leta V; Reker P; Fink GR; Ashkan K; Antonini A; Nimsky C; Visser-Vandewalle V; Martinez-Martin P; Ray Chaudhuri K; Timmermann L; Dafsari HS
    J Neurol Neurosurg Psychiatry; 2024 Jun; 95(7):630-638. PubMed ID: 38124227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.
    Nazzaro JM; Pahwa R; Lyons KE
    Parkinsonism Relat Disord; 2011 Sep; 17(8):606-9. PubMed ID: 21669545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.
    Lewis CJ; Maier F; Eggers C; Pelzer EA; Maarouf M; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2014 May; 20(5):514-9. PubMed ID: 24637125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease.
    Dafsari HS; Reker P; Silverdale M; Reddy P; Pilleri M; Martinez-Martin P; Rizos A; Perrier E; Weiß L; Ashkan K; Samuel M; Evans J; Visser-Vandewalle V; Antonini A; Ray-Chaudhuri K; Timmermann L;
    Neuromodulation; 2018 Aug; 21(6):532-540. PubMed ID: 29266613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease.
    Dafsari HS; Reddy P; Herchenbach C; Wawro S; Petry-Schmelzer JN; Visser-Vandewalle V; Rizos A; Silverdale M; Ashkan K; Samuel M; Evans J; Huber CA; Fink GR; Antonini A; Chaudhuri KR; Martinez-Martin P; Timmermann L;
    Brain Stimul; 2016; 9(1):78-85. PubMed ID: 26385442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.